Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI)…
NEW YORK (Reuters Health) – In patients with chronic hepatitis B virus (HBV) infection who are hepatitis B e antigen-positive, viral genotype is one of the strongest predictors…
NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to…
NEW YORK (Reuters Health) – While the risk of stroke after a transient ischemic attack (TIA) is highest in the first few days, stroke risk remains elevated even…
NEW YORK (Reuters Health) – Thoracic endovascular aortic repair (TEVAR) improves aortic remodeling in patients with stable dissection of the descending aorta, but it remains unclear whether long-term…
NEW YORK (Reuters Health) – Androgen suppression therapy – and its attendant side effects — may not be necessary for patients with intermediate-risk prostate cancer treated with combination…
NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It’s very…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, a body mass index (BMI) of 27.0 kg/meters-squared or higher increases the risk for left atrial/left atrial appendage…
NEW YORK (Reuters Health) – Endoscopic resection of large colonic polyps is a safe and cost-effective alternative to surgery, according to a paper in the December issue of…
NEW YORK (Reuters Health) – When allergic asthma in children can’t be controlled with medium- to high-dose corticosteroids, add-on omalizumab is effective and well tolerated, new research shows.…
